genome analysis for pathogens

About GenPAx

A synergistic team of expert scientists and experienced solution providers for customers, both locally and global, GenPAx is developing game-changing resources for the use of bacterial genome sequences for diagnostic genomics. Enabling more effective infection control strategies, and taking a lead in the fight against new and emergent pathogens and strains, antimicrobial resistance, and health-care and food-associated infections.

Join our community

Sign up for free to join the GenPAx community today.


Analysis and customer service

Our driving force

We are building a bacterial genomics company based on precision, efficiency and collaboration – the bedrocks of our company – and the driving forces behind all decisions; whether it’s how to analyse genomic sequences or the best way to serve our customers.

Our success and your satisfaction

We work in a highly competitive field, so we’re investing in technology and research to make sure we meet our promises and stay ahead of the curve. Our commitment to precision, efficiency and collaboration guarantees our success and your satisfaction.


Misuse & overuse of antimicrobials are the main drivers in the development of drug-resistant pathogens


On average, someone in the US gets an antibiotic resistant infection every 11 secs and every 15 mins someone dies


We are going to get more epidemics as biodiversity declines, population grows and proximity to animals increases

We are GenPAx

Sign up for free to join our community

GenPAx has a team of world class bioinformaticians developing new technology to detect outbreaks and tools to enable collaboration when they occur. We are looking for colleagues and partners to join us on this journey.

Shannon Rapp

VP, Finance & HR

Shannon Rapp's expertise in Finance and HR spans 30 years across a wide-range of industries. She specializes in growing start-up companies from infrastructure to culture. She excels at keeping companies focused to ensure both their strategic and organic development. Shannon is renowned for her extensive accounting experience, audit experience, and energetic drive.

When she's not helping companies successfully grow, Shannon spends her time scuba diving, practicing yoga, and walking her dogs on the beach.

Ray Schaaf

President, Inc.

Ray has over 30 years of experience spanning digital content, wireless, and e-commerce industries where he has held numerous executive positions managing companies in the USA, Asia, and Europe. He focuses on building successful companies with high quality teams that deliver creative products and services to the market.
Passions: skiing and hiking

Shannon Rapp

VP, Finance & HR

Shannon Rapp's expertise in Finance and HR spans 30 years across a wide-range of industries. She specializes in growing start-up companies from infrastructure to culture. She excels at keeping companies focused to ensure both their strategic and organic development. Shannon is renowned for her extensive accounting experience, audit experience, and energetic drive.

When she's not helping companies successfully grow, Shannon spends her time scuba diving, practicing yoga, and walking her dogs on the beach.

Julian Hardy

CEO

Julian Hardy is a serial entrepreneur with a proven track record of rapidly forming and building companies to the point product and revenue delivery. He’s been at the forefront of a number of innovative high growth technology sectors: mobile gaming, IoT, crypto and, Biotech. Bringing highly differentiated solutions to market, executing on a big vision. Julian’s strategic nature, energy, and communication skills make him a standout leader.

Father of 6, Julian is also a highly competitive cyclist and keen snowboarder.

Nigel Saunders

CSO

Nigel is an expert in clinical bacteriology and genomics. Most recently Interdisciplinary (Bioscience, Computer Science, & Maths) Professor of Systems Biology at Brunel University London, he was formerly head of the Bacterial Pathogenesis and Functional Genomics Group, at the Dunn School of Pathology, and Wellcome Fellow in Medical Microbiology at the Institute of Molecular Medicine, Oxford University. At Oxford he was also a Founding Manager of the Computational Biology Research Group.

Notable achievements include changing the use/monitoring of vancomycin antibiotics, contributions to the sequencing project underpinning the BEXSERO vaccine, and pioneering work in microarray comparative and functional genomics.

Nigel is also fully trained yoga instructor and runs classes out of his home studio in Devon.

[contact-form-7 404 "Not Found"]

[email-subscribers-form id="2"]

Home box

CSO

Nigel is an expert in clinical bacteriology and genomics. Most recently Interdisciplinary (Bioscience, Computer Science, & Maths) Professor of Systems Biology at Brunel University London, he was formerly head of the Bacterial Pathogenesis and Functional Genomics Group, at the Dunn School of Pathology, and Wellcome Fellow in Medical Microbiology at the Institute of Molecular Medicine, Oxford University. At Oxford he was also a Founding Manager of the Computational Biology Research Group.

Notable achievements include changing the use/monitoring of vancomycin antibiotics, contributions to the sequencing project underpinning the BEXSERO vaccine, and pioneering work in microarray comparative and functional genomics.

Nigel is also fully trained yoga instructor and runs classes out of his home studio in Devon.